Evidence map›Paper›PMID 26569211›Full record

ArticleMolecules (Basel, Switzerland)2015

Derinat Protects Skin against Ultraviolet-B (UVB)-Induced Cellular Damage.

Wen-Li Hsu, Jian-He Lu, Mami Noda, Ching-Ying Wu, Jia-Dai Liu, Manabu Sakakibara, Ming-Hsien Tsai, Hsin-Su Yu, Ming-Wei Lin, Yaw-Bin Huang and 2 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05450861 (Effect of the Composition From Fish on Promoting Hair Growth), which is not on this map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.0field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05450861 nacompletednot on this mapstarted 2020, after this paper: background citation

Effect of the Composition From Fish on Promoting Hair Growth

TypeinterventionalSponsorKaohsiung Medical University Chung-Ho Memorial HospitalRan2020 to 2021Enrolled53ConditionsHair Loss/Baldness, Androgenic Alopecia, Male Pattern Baldness, Female Pattern AlopeciaArmsSF DNA extraction composition, Placebo
3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. DerinatFrontiers in pharmacology · 2022
    Article
  5. A novel strategy for treating cancer: understanding the role of CaExploration of targeted anti-tumor therapy · 2021
    Review
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Wen-Li HsuThe Institute of Basic Medical Sciences, Medical of College, National Cheng Kung University, 1 University Road, Tainan 70101, Taiwan. mhtsai0522@gmail.com.
Jian-He LuGraduate Institute of Medicine, School of Medicine, Kaohsiung Medical University, No. 100, Shih-Chuan 1st Road, Kaohsiung 80708, Taiwan. toddherpuma@yahoo.com.tw.
Mami NodaLaboratory of Pathophysiology, Graduate School of Pharmaceutical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8581, Japan. mami@med.kyushu-u.ac.jp.
Ching-Ying WuGraduate Institute of Medicine, School of Medicine, Kaohsiung Medical University, No. 100, Shih-Chuan 1st Road, Kaohsiung 80708, Taiwan. yup.kmu@gmail.com.
Jia-Dai LiuLaboratory of Pathophysiology, Graduate School of Pharmaceutical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8581, Japan. liubeibei.35@163.com.
Manabu SakakibaraSchool of High-Technology for Human Welfare, Tokai University, 410-0321 Numazu, Shizuoka, Japan. msakaki@chime.ocn.ne.jp.
Ming-Hsien TsaiLipid Science and Aging Research Center, Kaohsiung Medical University, Kaohsiung 80708, Taiwan. mhtsai0522@gmail.com.
Hsin-Su YuDepartment of Dermatology, Kaohsiung Medical University, No. 100, Shih-Chuan 1st Road, Kaohsiung 80708, Taiwan. yup.kmu@gmail.com.
Ming-Wei LinSchool of Pharmacy, Kaohsiung Medical University, Kaohsiung 80708, Taiwan. tanukikimo@yahoo.com.tw.
Yaw-Bin HuangSchool of Pharmacy, Kaohsiung Medical University, Kaohsiung 80708, Taiwan. yabihu@kmu.edu.tw.
Shian-Jang YanThe Institute of Basic Medical Sciences, Medical of College, National Cheng Kung University, 1 University Road, Tainan 70101, Taiwan. DROSOUV@gmail.com.
Tohru YoshiokaLipid Science and Aging Research Center, Kaohsiung Medical University, Kaohsiung 80708, Taiwan. yoshitohru@gmail.com.
Kaohsiung Medical University · TWKyushu University · JPNational Cheng Kung University · TWTokai University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ultraviolet-B (UVB) is one of the most cytotoxic and mutagenic stresses that contribute to skin damage and aging through increasing intracellular Ca(2+) and reactive oxygen species (ROS). Derinat (sodium deoxyribonucleate) has been utilized as an immunomodulator for the treatment of ROS-associated diseases in clinics. However, the molecular mechanism by which Derinat protects skin cells from UVB-induced damage is poorly understood. Here, we show that Derinat significantly attenuated UVB-induced intracellular ROS production and decreased DNA damage in primary skin cells. Furthermore, Derinat reduced intracellular ROS, cyclooxygenase-2 (COX-2) expression and DNA damage in the skin of the BALB/c-nu mice exposed to UVB for seven days in vivo. Importantly, Derinat blocked the transient receptor potential canonical (TRPC) channels (TRPCs), as demonstrated by calcium imaging. Together, our results indicate that Derinat acts as a TRPCs blocker to reduce intracellular ROS production and DNA damage upon UVB irradiation. This mechanism provides a potential new application of Derinat for the protection against UVB-induced skin damage and aging.

Indexed as

AnimalsCalciumCell LineCyclooxygenase 2DNADNA DamageGene ExpressionHumansKeratinocytesMiceMice, Inbred BALB COxidative StressProtective AgentsReactive Oxygen SpeciesSkinUltraviolet RaysCalciumCyclooxygenase 2DerinatDNAProtective AgentsReactive Oxygen SpeciescalciumDerinatROSTRPCsUVB

Identifiers

PMID26569211
PMCPMC6331914
OpenAlexW2151561114

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.